Myriad Genetics | MYGN - EPS Earnings Per Share


Myriad Genetics reported $-0.09 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q2 Jun/2026 -0.06 0.05 Jul/30
FY2025Q1 Mar/2026 -0.09 -0.07 -0.03 May/05




Eps Change Date
Agilent USD 1.43 0.11 Mar/2026
Becton, Dickinson and Co. USD 2.9 0.01 Mar/2026
Bio-Rad Laboratories USD 1.89 0.62 Mar/2026
Bruker USD 0.31 0.28 Mar/2026
Danaher USD 2.06 0.17 Mar/2026
Illumina USD 1.15 0.2 Mar/2026
J&J USD 2.7 0.24 Mar/2026
Mettler Toledo International USD 8.91 4.45 Mar/2026
Myriad Genetics USD -0.09 0.13 Mar/2026
OraSure Technologies USD -0.18 0 Dec/2025
Pacific Biosciences Of California USD -0.17 0.12 Dec/2025
Quest Diagnostics USD 2.5 0.08 Mar/2026
Quidel USD 0.04 0.42 Mar/2026
Repligen USD 0.48 0.01 Mar/2026
Revvity USD 1.06 0.64 Mar/2026
Standard Biotools USD 0.33 0.29 Mar/2026
Thermo Fisher Scientific USD 5.44 1.13 Mar/2026
Veracyte USD 0.52 0.01 Mar/2026
Waters USD 2.7 1.83 Mar/2026